Extensive studies have shown that PRMT5 is overexpressed in varieties of human lymphoid malignancies and solid tumors, and it facilitates survival and proliferation of cancer cells (Chan-Penebre et al., 2015[5]; Harris et al., 2014[8]; Karkhanis et al., 2011[13]). This evidence concerns the gene PRMT5 and cancer.